Avascular Necrosis of the Femoral Head
LEARN MOREAvascular Necrosis of the Femoral Head
Diagnosis
Have you been diagnosed with suspected avascular necrosis of the femoral head?
What is it about?
Necrosis of the femoral head is the result of a vascularization defect of the femoral head and consequent resorption of the bone tissue in a delimited area, such as to induce a degeneration of the entire joint.
It is a more frequent pathology in males between the ages of thirty and sixty and can be bilateral.
Causes
The causes can be multiple both of a traumatic or non-traumatic nature.
In the case of a trauma we can have a vascular lesion and a decrease in the perfusion of the femoral head, in non-traumatic conditions it is often difficult to understand the causes. Often the etiopathogenesis of osteonecrosis is determined by concomitant factors: drug intake (eg cortisone for long periods), alcohol, diabetes, metabolic diseases, coagulation disorders and other factors can contribute.
Symptoms
The patient begins to experience pain in the hip especially after exertion and in some movements (eg putting on stockings) with consequent lameness. Pain is usually the symptom of onset and has a sudden onset, it can be referred to the groin, radiated to the anterior or anteromedial aspect of the thigh and more rarely to the buttock. Pain is often present even at rest but the load and walking aggravate it significantly.
Diagnosis
Traditional radiographs may show modest density changes in the bone texture or may show changes in the morphology of the deformed femoral head. The first radiographic findings of osteonecrosis can be evident even after about 3 months. The CT scan can help to define the extent of the lesion and the degree of bone collapse in the most advanced states but the MRI represents the diagnostic method of choice as it allows to discover the lesions early even before they are visible in traditional radiographs.
Treatments
Initially, treatment consists of limb discharge, osteoporosis-like drug therapy, physical therapies such as magneto therapy and hyperbaric oxygen therapy. Growth factors are successfully used in the initial stages of the disease, however it is a difficult challenge since recovery is not always achieved; moreover, in the earliest stages of the lesion the patient is often asymptomatic and the disorders appear when the treatment options are only surgical and in young patients with high functional demands, prosthetic hip replacement is at greater risk of wear and failure. In consideration of the early age in which the disease often manifests itself and, consequently, of the high functional demands, the importance of “biological” therapeutic options emerges that allow to spare the joint, avoiding the collapse of the femoral head.
The research perspectives on which we have been focusing for some years are aimed at the study of the pathophysiology of the disease and the use of autologous growth factors and mesenchymal cells that are proving to be fundamental in promoting the processes of reparative osteogenesis.
.
After the surgical treatment it is necessary to limit the load on the hip and follow a careful rehabilitation protocol.